PCM
AGN

Parsons Capital Management’s Allergan Inc AGN Stock Holding History

Parsons Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-6,025
Closed -$1.28M – 615
2014
Q4 		$1.28M Hold
6,025
– – 0.17% 138
2014
Q3 		$1.07M Sell
6,025
-20
-0.3% -$3.32K 0.15% 155
2014
Q2 		$1.02M Sell
6,045
-4,879
-45% -$760K 0.14% 157
2014
Q1 		$1.36M Sell
10,924
-275
-2% -$33.5K 0.19% 137
2013
Q4 		$1.24M Buy
11,199
+25
+0.2% +$2.39K 0.19% 135
2013
Q3 		$1.01M Sell
11,174
-75
-0.7% -$6.73K 0.17% 150
2013
Q2 		$947K Buy
+11,249
New +$1.17M 0.16% 147

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Parsons Capital Management's AGN Position: Q1 2015 in Review

Parsons Capital Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 6,025 shares — an estimated $1.28M sold.

Parsons Capital Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $1.36M in Q1 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Parsons Capital Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Parsons Capital Management sold 6,025 Allergan Inc shares in Q1 2015, an estimated $1.28M.
  • Parsons Capital Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Parsons Capital Management's Allergan Inc position peaked at $1.36M in Q1 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Parsons Capital Management's 13F filing for Q1 2015, filed 8 May 2015.